Friday, October 2, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 25, 2026

Arteris Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026

View original at finance.yahoo.com
Arteris Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 Arteris, Inc. Arteris joins the ranks of Google, Nvidia, Adidas, Walmart, and more in Fast Company’s annual World’s Most Innovative Companies of 2026 list…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Arteris is focused on solving the industry's toughest challenges as AI and chiplet-based architectures continue to evolve, from automating complex network-on-chip creation to enabling secure, scalable data movement for billions of chips

    60% confidence
  • FlexGen enables teams to generate optimized interconnects in a fraction of the time with significantly improved power, performance, and area results

    60% confidence
  • Arteris is focused on solving the industry's toughest challenges as AI and chiplet-based architectures continue to evolve, from automating complex network-on-chip creation to enabling secure, scalable data movement for billions of chips

    60% confidence
  • Arteris is committed to addressing rapid changes in the semiconductor industry and setting new standards for innovation

    60% confidence
  • FlexGen is the industry's first smart network-on-chip (NoC) IP

    60% confidence
  • Arteris is honored to receive Fast Company recognition as it reflects their commitment to addressing rapid changes in the semiconductor industry and setting new standards for innovation

    60% confidence
  • Arteris is committed to addressing rapid changes in the semiconductor industry and setting new standards for what is possible through innovation

    60% confidence
  • FlexGen is the industry's first smart network-on-chip IP

    60% confidence
  • Arteris is committed to addressing rapid changes in the semiconductor industry and setting new standards for what is possible through innovation

    60% confidence
  • FlexGen enables teams to generate optimized interconnects in a fraction of the time with significantly improved power, performance, and area (PPA) results

    60% confidence
  • Arteris is focused on solving the industry's toughest challenges as AI and chiplet-based architectures continue to evolve

    60% confidence
  • FlexGen enables teams to generate optimized interconnects in a fraction of the time with significantly improved power, performance, and area results

    60% confidence
  • Arteris network-on-chip technology has been shipped in more than 4 billion chips and chiplets for major customers and numerous emerging AI innovators globally

    60% confidence
  • Arteris is focused on solving the industry's toughest challenges as AI and chiplet-based architectures continue to evolve, from automating complex network-on-chip creation to enabling secure, scalable data movement

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com